Related Experiment Video

Updated: May 20, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

[An update on the secondary prevention of cerebral infarction due to atrial fibrillation]

Fernando Barinagarrementeria Aldatz1

  • 1División de Ciencias de la Salud, Universidad del Valle de México, Hospital Ángeles de Querétaro, Querétaro, Qro. fbarinaga@prodigy.net.mx

Gaceta Medica De Mexico
|July 24, 2012
PubMed

Insights

Atrial fibrillation (AF) significantly increases stroke risk. Early detection and risk stratification are crucial for preventing strokes in AF patients, with new oral anticoagulants offering improved safety and convenience.

Area of Science:

  • Cardiology
  • Neurology
  • Public Health

Context:

  • Stroke is a leading global cause of death and disability.
  • Atrial fibrillation (AF) is a primary risk factor for cardioembolic stroke.
  • Mexico has a substantial population affected by AF, estimated at 850,000.

Purpose:

  • To highlight the importance of Atrial Fibrillation (AF) detection in stroke patients.
  • To discuss risk stratification strategies for stroke in AF patients.
  • To review current and emerging anticoagulation therapies for stroke prevention in AF.

Summary:

  • Atrial fibrillation (AF) increases stroke risk sixfold, with significant prevalence in Mexican stroke and TIA cohorts (12.5% and 8.1%).
  • Non-invasive cardiac monitoring aids in detecting AF, especially paroxysmal AF in cryptogenic stroke.
  • Risk scores like CHADS2 and CHA2DS2-VASc aid in stratifying stroke risk in AF patients.

Impact:

  • Improved identification of high-risk individuals for timely intervention.
  • Enhanced stroke prevention strategies through effective AF management.
  • Facilitation of informed clinical decisions regarding anticoagulation therapy, including newer agents.

More Related Videos

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...